Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 880965

Implementation of Pharmacoeconomics to Support Pharmaceutical R&D Decisions: Workshop


Kaló, Zoltan; Vitezić, Dinko
Implementation of Pharmacoeconomics to Support Pharmaceutical R&D Decisions: Workshop // Abstracts Presented at the European Association for Clinical Pharmacology and Therapeutics Focus Meeting 2016: How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic– 3E Assessment / Richard I. Shader (ur.).
Amsterdam : Boston : Jena : London: Elsevier, 2016. str. e19-e19 (predavanje, međunarodna recenzija, sažetak, stručni)


CROSBI ID: 880965 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Implementation of Pharmacoeconomics to Support Pharmaceutical R&D Decisions: Workshop

Autori
Kaló, Zoltan ; Vitezić, Dinko

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni

Izvornik
Abstracts Presented at the European Association for Clinical Pharmacology and Therapeutics Focus Meeting 2016: How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic– 3E Assessment / Richard I. Shader - Amsterdam : Boston : Jena : London : Elsevier, 2016, E19-e19

Skup
European Association for Clinical Pharmacology and Therapeutics Focus Meeting 2016

Mjesto i datum
Opatija, Hrvatska, 06.10.2016. - 09.10.2016

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Pharmacoeconomics ; Pharmaceutical R&D Decisions ; Workshop

Sažetak
Learning Objectives: 1. To facilitate the utilization of health economic input into pharmaceutical R&D decisions ; 2. To develop technical skills in the application of economic models to translate the “target product profile” to strategic pricing assumptions and consequently to conduct “go & no go” decisions Course Description: Assessment of the economic value is increasingly important in the pricing and reimbursement process of new pharmaceuticals due to the scarcity of public resources. As a consequence, pharmaceutical research and development face the need for a new type of development strategy. In the R&D process, health economic aspects should be taken into account, especially in 1) the priorisation of research areas, 2) the pricing assumptions of drug candidates, and 3) the go & no go decisions of drug candidates, including the selection of target indications. The workshop provides a theoretical overview of health economic activities in the R&D process and provides pragmatic case studies on how to make decisions in the real world. General presentations will introduce the topic. Then a series of password protected economic models will add more and more complexity to a pragmatic case study on a drug candidate in 3 potential indications. Participants should calculate the “economically justifiable price” and apply this information for making “go & no go” decisions. Participants should bring their own computers with Excel software to complete the case study. Level: Intermediate. This course is designed for clinical pharmacologists, R&D experts, and decision-makers (including public policymakers and regulators, academia, and industry) who are wishing to understand the applicability and technical aspects of health economic methodologies to support the evidence base of R&D decisions. Course structure: Health policy environment for new pharmaceuticals: Lecture Strategic imperatives of pharmaceutical R&D: Lecture Health economic support in the R&D process: Lecture Principles of strategic pricing: Lecture Strategic pricing (case study): Computer exercise Principles of “go & no go” decisions: Lecture & Discussion “Go & no go” decisions (case study): Computer exercise Prereading: Bodrogi J, Kaló Z. Principles of pharmacoeconomics and their impact on strategic imperatives of pharmaceutical research and development. Br J Pharmacol. 2010. 159. 7. 1367-73.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
062-0620063-0060 - Uporaba kardiovaskularnih lijekova i značaj farmakoekonomskih procjena (Vitezić, Dinko, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Rijeka

Profili:

Avatar Url Dinko Vitezić (autor)

Citiraj ovu publikaciju:

Kaló, Zoltan; Vitezić, Dinko
Implementation of Pharmacoeconomics to Support Pharmaceutical R&D Decisions: Workshop // Abstracts Presented at the European Association for Clinical Pharmacology and Therapeutics Focus Meeting 2016: How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic– 3E Assessment / Richard I. Shader (ur.).
Amsterdam : Boston : Jena : London: Elsevier, 2016. str. e19-e19 (predavanje, međunarodna recenzija, sažetak, stručni)
Kaló, Z. & Vitezić, D. (2016) Implementation of Pharmacoeconomics to Support Pharmaceutical R&D Decisions: Workshop. U: Richard I. Shader (ur.)Abstracts Presented at the European Association for Clinical Pharmacology and Therapeutics Focus Meeting 2016: How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic– 3E Assessment.
@article{article, author = {Kal\'{o}, Zoltan and Vitezi\'{c}, Dinko}, year = {2016}, pages = {e19-e19}, keywords = {Pharmacoeconomics, Pharmaceutical R and D Decisions, Workshop}, title = {Implementation of Pharmacoeconomics to Support Pharmaceutical R and D Decisions: Workshop}, keyword = {Pharmacoeconomics, Pharmaceutical R and D Decisions, Workshop}, publisher = {Elsevier}, publisherplace = {Opatija, Hrvatska} }
@article{article, author = {Kal\'{o}, Zoltan and Vitezi\'{c}, Dinko}, year = {2016}, pages = {e19-e19}, keywords = {Pharmacoeconomics, Pharmaceutical R and D Decisions, Workshop}, title = {Implementation of Pharmacoeconomics to Support Pharmaceutical R and D Decisions: Workshop}, keyword = {Pharmacoeconomics, Pharmaceutical R and D Decisions, Workshop}, publisher = {Elsevier}, publisherplace = {Opatija, Hrvatska} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font